Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6312514, 8 pages
https://doi.org/10.1155/2017/6312514
Review Article

Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection

1Department of Surgery, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA
2Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA

Correspondence should be addressed to T. Mohanakumar; gro.htlaehytingid@ramuk.mt

Received 21 September 2016; Accepted 6 December 2016; Published 9 January 2017

Academic Editor: Junchao Cai

Copyright © 2017 Ankit Bharat and T. Mohanakumar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bharat and T. Mohanakumar, “Allopeptides and the alloimmune response,” Cellular Immunology, vol. 248, no. 1, pp. 31–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Bharat, K. Narayanan, T. Street et al., “Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection,” Transplantation, vol. 83, no. 2, pp. 150–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Bharat, E. Kuo, N. Steward et al., “Immunological link between primary graft dysfunction and chronic lung allograft rejection,” The Annals of Thoracic Surgery, vol. 86, no. 1, pp. 189–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. D. Snyder, Z. Wang, D.-F. Chen et al., “Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients,” Chest, vol. 144, no. 1, pp. 226–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Campbell, “Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation,” Current Opinion in Organ Transplantation, vol. 18, no. 4, pp. 463–469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Heng, L. D. Sharples, K. McNeil, S. Stewart, T. Wreghitt, and J. Wallwork, “Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors,” Journal of Heart and Lung Transplantation, vol. 17, no. 12, pp. 1255–1263, 1998. View at Google Scholar · View at Scopus
  7. M. Liu, V. Subramanian, C. Christie, M. Castro, and T. Mohanakumar, “Immune responses to self-antigens in asthma patients: clinical and immunopathological implications,” Human Immunology, vol. 73, no. 5, pp. 511–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bharat, R. C. Fields, N. Steward, E. P. Trulock, G. A. Patterson, and T. Mohanakumar, “CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation,” American Journal of Transplantation, vol. 6, no. 8, pp. 1799–1808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Burlingham, R. B. Love, E. Jankowska-Gan et al., “IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants,” Journal of Clinical Investigation, vol. 117, no. 11, pp. 3498–3506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. A. Goers, S. Ramachandran, A. Aloush, E. Trulock, G. A. Patterson, and T. Mohanakumar, “De novo production of K-α1 tubulin-specific antibodies: role in chronic lung allograft rejection,” The Journal of Immunology, vol. 180, no. 7, pp. 4487–4494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Bharat, D. Saini, N. Steward et al., “Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection,” Annals of Thoracic Surgery, vol. 90, no. 4, pp. 1094–1100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Iwata, A. Philipovskiy, A. J. Fisher et al., “Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction,” The Journal of Immunology, vol. 181, no. 8, pp. 5738–5747, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Saini, J. Weber, S. Ramachandran et al., “Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts,” Journal of Heart and Lung Transplantation, vol. 30, no. 6, pp. 624–631, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bharat and T. Mohanakumar, “Autoimmunity and lung transplantation,” Frontiers in Bioscience, vol. 4, pp. 2378–2388, 2012. View at Google Scholar
  15. B. D. Tait, C. Süsal, H. M. Gebel et al., “Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation,” Transplantation, vol. 95, no. 1, pp. 19–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. P. Legoux, J.-B. Lim, A. W. Cauley et al., “CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells rather than deletion,” Immunity, vol. 43, no. 5, pp. 896–908, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. E. E. Sercarz, P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil, “Dominance and crypticity of T cell antigenic determinants,” Annual Review of Immunology, vol. 11, pp. 729–766, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Ciubotariu, A. I. Colovai, G. Pennesi et al., “Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28 regulatory T cells,” The Journal of Immunology, vol. 161, no. 10, pp. 5193–5202, 1998. View at Google Scholar · View at Scopus
  19. Z. Liu, A. I. Colovai, S. Tugulea et al., “Indirect recognition of donor HLA-DR peptides in organ allograft rejection,” Journal of Clinical Investigation, vol. 98, no. 5, pp. 1150–1157, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. B. M. Tesar, D. Jiang, J. Liang, S. M. Palmer, P. W. Noble, and D. R. Goldstein, “The role of hyaluronan degradation products as innate alloimmune agonists,” American Journal of Transplantation, vol. 6, no. 11, pp. 2622–2635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. R. Hachem, V. Tiriveedhi, G. A. Patterson, A. Aloush, E. P. Trulock, and T. Mohanakumar, “Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation,” American Journal of Transplantation, vol. 12, no. 8, pp. 2164–2171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Fukami, S. Ramachandran, D. Saini et al., “Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection,” Journal of Immunology, vol. 182, no. 1, pp. 309–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Afzali, G. Lombardi, R. I. Lechler, and G. M. Lord, “The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease,” Clinical and Experimental Immunology, vol. 148, no. 1, pp. 32–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Ludewig, R. M. Zinkernagel, and H. Hengartner, “Transgenic animal models for virus-induced autoimmune diseases,” Experimental Physiology, vol. 85, no. 6, pp. 653–659, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. L. E. Muñoz, C. Janko, C. Schulze et al., “Autoimmunity and chronic inflammation—two clearance-related steps in the etiopathogenesis of SLE,” Autoimmunity Reviews, vol. 10, no. 1, pp. 38–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Hu, J. S. Lee, P. T. Pianosi, and J. H. Ryu, “Aspiration-related pulmonary syndromes,” Chest, vol. 147, no. 3, pp. 815–823, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Bobadilla, E. Jankowska-Gan, Q. Xu et al., “Reflux-induced collagen type V sensitization: potential mediator of bronchiolitis obliterans syndrome,” Chest, vol. 138, no. 2, pp. 363–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. G. Hartwig and R. D. Davis, “Gastroesophageal reflux disease-induced aspiration injury following lung transplantation,” Current Opinion in Organ Transplantation, vol. 17, no. 5, pp. 474–478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Hoppo, V. Jarido, A. Pennathur et al., “Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation,” Archives of Surgery, vol. 146, no. 9, pp. 1041–1047, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. Weber and D. S. Wilkes, “The role of autoimmunity in obliterative bronchiolitis after lung transplantation,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 304, no. 5, pp. L307–L311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. A. Shilling and D. S. Wilkes, “Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond,” American Journal of Transplantation, vol. 9, no. 8, pp. 1714–1718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Z. Atassi and P. Casali, “Molecular mechanisms of autoimmunity,” Autoimmunity, vol. 41, no. 2, pp. 123–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Adeegbe, T. Matsutani, J. Yang, N. H. Altman, and T. R. Malek, “CD4+ CD25+ Foxp3+ T regulatory cells with limited TCR diversity in control of autoimmunity,” The Journal of Immunology, vol. 184, no. 1, pp. 56–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. N. J. Dorsey, S. P. Chapoval, E. P. Smith, J. Skupsky, D. W. Scott, and A. D. Keegan, “STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation,” The Journal of Immunology, vol. 191, no. 4, pp. 1517–1528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Soroosh, T. A. Doherty, W. Duan et al., “Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance,” Journal of Experimental Medicine, vol. 210, no. 4, pp. 775–788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Von Boehmer, “Mechanisms of suppression by suppressor T cells,” Nature Immunology, vol. 6, no. 4, pp. 338–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Sakaguchi, M. Ono, R. Setoguchi et al., “Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease,” Immunological Reviews, vol. 212, pp. 8–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. D. A. A. Vignali, L. W. Collison, and C. J. Workman, “How regulatory T cells work,” Nature Reviews Immunology, vol. 8, no. 7, pp. 523–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. E. M. Shevach, “Biological functions of regulatory T cells,” Advances in Immunology, vol. 112, pp. 137–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Tosiek, A. D. Gruber, S. R. Bader et al., “CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation,” The Journal of Immunology, vol. 186, no. 11, pp. 6106–6118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. W. Zhou, X. Zhou, S. Gaowa et al., “The critical role of induced CD4+ FoxP3+ regulatory cells in suppression of interleukin-17 production and attenuation of mouse orthotopic lung allograft rejection,” Transplantation, vol. 99, no. 7, pp. 1356–1364, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Bharat, E. Kuo, D. Saini et al., “Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection,” Annals of Thoracic Surgery, vol. 90, no. 5, pp. 1637–1644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Kuo, A. Bharat, T. Goers et al., “Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation,” Annals of Thoracic Surgery, vol. 82, no. 3, pp. 1043–1050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. Ercolini and S. D. Miller, “The role of infections in autoimmune disease,” Clinical and Experimental Immunology, vol. 155, no. 1, pp. 1–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Chiu, R. Fernandez, V. Subramanian et al., “Lung injury combined with loss of regulatory T cells leads to de novo lung-restricted autoimmunity,” The Journal of Immunology, vol. 197, no. 1, pp. 51–57, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Tiriveedhi, B. Gautam, N. J. Sarma et al., “Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations,” Journal of Heart and Lung Transplantation, vol. 32, no. 8, pp. 807–814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. P. D. Shah and J. F. McDyer, “Viral infections in lung transplant recipients,” Seminars in Respiratory and Critical Care Medicine, vol. 31, no. 2, pp. 243–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Uhlin, J. Mattsson, and M. Maeurer, “Update on viral infections in lung transplantation,” Current Opinion in Pulmonary Medicine, vol. 18, no. 3, pp. 264–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Papakonstantinou, G. Karakiulakis, S. Batzios et al., “Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection,” Respiratory Research, vol. 16, no. 1, article 78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Meyer and I. Jaspers, “Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants,” American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 308, no. 12, pp. 1189–1201, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Gunasekaran, Z. Xu, D. K. Nayak et al., “Donor-derived exosomes with lung self-antigens in human lung allograft rejection,” American Journal of Transplantation, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Admyre, E. Telemo, N. Almqvist et al., “Exosomes—nanovesicles with possible roles in allergic inflammation,” Allergy, vol. 63, no. 4, pp. 404–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. J. P. J. J. Hegmans, P. J. Gerber, and B. N. Lambrecht, “Exosomes,” Methods in Molecular Biology, vol. 484, pp. 97–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Admyre, S. M. Johansson, S. Paulie, and S. Gabrielsson, “Direct exosome stimulation of peripheral human T cells detected by ELISPOT,” European Journal of Immunology, vol. 36, no. 7, pp. 1772–1781, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. J. L. Bobadilla, R. B. Love, E. Jankowska-Gan et al., “Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 6, pp. 660–668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. R. R. Hachem, A. P. Khalifah, M. M. Chakinala et al., “The significance of a single episode of minimal acute rejection after lung transplantation,” Transplantation, vol. 80, no. 10, pp. 1406–1413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. S. A. Yousem, G. J. Berry, P. T. Cagle et al., “Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung Rejection Study Group,” Journal of Heart and Lung Transplantation, vol. 15, no. 1, part 1, pp. 1–15, 1996. View at Google Scholar · View at Scopus
  58. D. Kreisel, S. Sugimoto, J. Zhu et al., “Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance,” Blood, vol. 118, no. 23, pp. 6172–6182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Inci, B. Erne, S. Arni et al., “Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia,” The Journal of Heart and Lung Transplantation, vol. 29, no. 11, pp. 1293–1301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Grimm, V. Valero, A. Kilic et al., “Association between prolonged graft ischemia and primary graft failure or survival following lung transplantation,” JAMA Surgery, vol. 150, no. 6, pp. 547–553, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Bharat, “Prolonged lung allograft ischemia and posttransplant outcome,” JAMA Surgery, vol. 150, no. 6, p. 554, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Fernandez, S. Chiu, K. Raparia et al., “Humoral human lung allograft rejection by tissue-restricted non-HLA antibodies,” The Annals of Thoracic Surgery, vol. 102, no. 4, pp. e339–e341, 2016. View at Publisher · View at Google Scholar
  63. J. M. Diamond and J. D. Christie, “The contribution of airway and lung tissue ischemia to primary graft dysfunction,” Current Opinion in Organ Transplantation, vol. 15, no. 5, pp. 552–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Berry, M. Burke, C. Andersen et al., “Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT,” The Journal of Heart and Lung Transplantation, vol. 32, no. 1, pp. 14–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. W. D. Wallace, S. S. Weigt, and C. F. Farver, “Update on pathology of antibody-mediated rejection in the lung allograft,” Current Opinion in Organ Transplantation, vol. 19, no. 3, pp. 303–308, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. C. A. Witt, J. P. Gaut, R. D. Yusen et al., “Acute antibody-mediated rejection after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 32, no. 10, pp. 1034–1040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. A. R. Glanville, “Antibody-mediated rejection in lung transplantation: turning myth into reality,” Journal of Heart and Lung Transplantation, vol. 32, no. 1, pp. 12–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Stewart, M. C. Fishbein, G. I. Snell et al., “Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection,” The Journal of Heart and Lung Transplantation, vol. 26, no. 12, pp. 1229–1242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. G. P. Westall, G. I. Snell, C. McLean, T. Kotsimbos, T. Williams, and C. Magro, “C3d and C4d deposition early after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 27, no. 7, pp. 722–728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Burlingham, D. S. Wilkes, and J. A. Sullivan, “Why is the patient out of breath? collagen V(α1) and K-α1-tubulin take center stage in lung transplantation,” American Journal of Transplantation, vol. 14, no. 10, pp. 2201–2203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Bharat, S. Chiu, Z. Zheng et al., “Lung-restricted antibodies mediate primary graft dysfunction and prevent allotolerance after murine lung transplantation,” American Journal of Respiratory Cell and Molecular Biology, vol. 55, no. 4, pp. 532–541, 2016. View at Publisher · View at Google Scholar
  72. V. Subramanian, S. Ramachandran, B. Banan et al., “Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation,” American Journal of Transplantation, vol. 14, no. 10, pp. 2359–2366, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. M. A. Haque, T. Mizobuchi, K. Yasufuku et al., “Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection,” Journal of Immunology, vol. 169, no. 3, pp. 1542–1549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Jaramillo, M. A. Smith, D. Phelan et al., “Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation,” Transplantation, vol. 67, no. 8, pp. 1155–1161, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Saini, N. Angaswamy, V. Tiriveedhi et al., “Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation,” Journal of Heart and Lung Transplantation, vol. 29, no. 12, pp. 1330–1336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. M. T. Rees, J. Downing, and C. Darke, “A typing system for the Major Histocompatibility Complex class I chain related genes A and B using polymerase chain reaction with sequence-specific primers,” Genetic Testing, vol. 9, no. 2, pp. 93–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. H. A. F. Stephens, “MICA and MICB genes: can the enigma of their polymorphism be resolved?” Trends in Immunology, vol. 22, no. 7, pp. 378–385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. D. H. Raulet, “Roles of the NKG2D immunoreceptor and its ligands,” Nature Reviews Immunology, vol. 3, no. 10, pp. 781–790, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Sumitran-Holgersson, “Relevance of MICA and other non-HLA antibodies in clinical transplantation,” Current Opinion in Immunology, vol. 20, no. 5, pp. 607–613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. N. Angaswamy, D. Saini, S. Ramachandran et al., “Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation,” Human Immunology, vol. 71, no. 6, pp. 560–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Weis and W. von Scheidt, “Cardiac allograft vasculopathy: a review,” Circulation, vol. 96, no. 6, pp. 2069–2077, 1997. View at Publisher · View at Google Scholar · View at Scopus
  82. X. Yuan, J. Paez-Cortez, I. Schmitt-Knosalla et al., “A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy,” Journal of Experimental Medicine, vol. 205, no. 13, pp. 3133–3144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. M. L. Rose and J. D. Smith, “Clinical relevance of complement-fixing antibodies in cardiac transplantation,” Human Immunology, vol. 70, no. 8, pp. 605–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. I. Kaczmarek, M.-A. Deutsch, T. Kauke et al., “Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant,” Experimental and Clinical Transplantation, vol. 6, no. 3, pp. 229–235, 2008. View at Google Scholar · View at Scopus
  85. P. T. Jindra, A. Hsueh, L. Hong et al., “Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts,” Journal of Immunology, vol. 180, no. 4, pp. 2214–2224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. M. E. Atz and E. F. Reed, “Role of anti-MHC class I antibody in facilitating transplant accommodation,” Critical Reviews in Immunology, vol. 28, no. 6, pp. 485–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. D. S. Nath, H. I. Basha, V. Tiriveedhi et al., “Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy,” Journal of Heart and Lung Transplantation, vol. 29, no. 11, pp. 1277–1285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. H. S. Leong, B. M. Mahesh, J. R. Day et al., “Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor,” Journal of Leukocyte Biology, vol. 83, no. 2, pp. 263–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. D. S. Nath, N. Angaswamy, H. I. Basha et al., “Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation,” Human Immunology, vol. 71, no. 12, pp. 1191–1196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. Q. Zhang, J. M. Cecka, D. W. Gjertson et al., “HLA and MICA: targets of antibody-mediated rejection in heart transplantation,” Transplantation, vol. 91, no. 10, pp. 1153–1158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Hertig, D. Anglicheau, J. Verine et al., “Early epithelial phenotypic changes predict graft fibrosis,” Journal of the American Society of Nephrology, vol. 19, no. 8, pp. 1584–1591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. D. Dragun, D. N. Müller, J. H. Bräsen et al., “Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection,” New England Journal of Medicine, vol. 352, no. 6, pp. 558–569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Fotheringham, C. A. Angel, and W. McKane, “Transplant glomerulopathy: morphology, associations and mechanism,” Nephron Clinical Practice, vol. 113, no. 1, pp. c1–c7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Li, M. E. Atz, and E. F. Reed, “Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways,” Current Opinion in Immunology, vol. 21, no. 5, pp. 557–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Li and C. W. Yang, “The pathogenesis and treatment of chronic allograft nephropathy,” Nature Reviews Nephrology, vol. 5, no. 9, pp. 513–519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. S. A. Joosten, Y. W. J. Sijpkens, V. Van Ham et al., “Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy,” American Journal of Transplantation, vol. 5, no. 2, pp. 383–393, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Berenguer, F. X. López-Labrador, and T. L. Wright, “Hepatitis C and liver transplantation,” Journal of Hepatology, vol. 35, no. 5, pp. 666–678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. B. B. Borg, A. Seetharam, V. Subramanian et al., “Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis,” Liver Transplantation, vol. 17, no. 7, pp. 814–823, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. V. Subramanian, A. Bharat, N. Vachharajani et al., “Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients,” HPB, vol. 16, no. 3, pp. 282–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Bharat, F. Barros, K. Narayanan et al., “Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis,” American Journal of Transplantation, vol. 8, no. 6, pp. 1214–1220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Bharat, K. Narayanan, A. Golocheikine et al., “Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis,” Transplantation, vol. 84, no. 12, pp. 1704–1707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Tiriveedhi, N. Angaswamy, J. Weber, and T. Mohanakumar, “Lipid raft facilitated ligation of K-α1-tubulin by specific antibodies on epithelial cells: role in pathogenesis of chronic rejection following human lung transplantation,” Biochemical and Biophysical Research Communications, vol. 399, no. 2, pp. 251–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. V. Tiriveedhi, A. E. Gelman, and T. Mohanakumar, “HIF-1alpha signaling by airway epithelial cell K-alpha1-tubulin: role in fibrosis and chronic rejection of human lung allografts,” Cellular Immunology, vol. 273, no. 1, pp. 59–66, 2012. View at Publisher · View at Google Scholar · View at Scopus